ArticleCureus2022
A Young Male With an Active Giant Cell Tumor: A Case Report.
Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A giant cell tumor (GCT) is a benign but locally aggressive tumor usually present over the knee joint. Its etiology is unknown but some studies have shown that it appears due to overexpression in RANK/RANKL by neoplastic mononuclear stromal cells signaling pathway, which results in hyperproliferation of osteoclasts. This is a case of a 25-year-old male who presented with swelling associated with pain over his left distal femur since eight months. The range of motion (ROM) at the knee joint was painful from 0 to 110 degrees and no knee effusion was observed. Examination revealed a slightly mobile mass present over the knee joint. Additional preoperative workup such as Computed Tomography (CT) scan and Magnetic Resonance Imaging (MRI) was done. Histopathological findings showed the presence of large multinucleated osteoclast-like giant cells. Radiographs showed a permeative lytic lesion within the distal femur with surrounding cortical destruction. Surgical excision by curettage and bone grafting was done. The patient did well, without clinical recurrence at one-year follow-up. A local recurrence rate of 2.5 to 45% is observed. Aggressive operative excision, use of adjuvants at the time of resection, and ongoing postoperative monitoring can decrease patient morbidity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.